Datascope will retain approximately $38 million of receivables generated by the patient monitoring business. The transaction has been approved by the Datascope and Mindray boards of directors and
The companies will focus on phage-based products that could help the animal health and food production industries in their struggle to control outbreaks of human pathogenic bacteria such
Schering-Plough is seeking FDA approval to sell the product in the US over-the-counter (OTC) heartburn market. The NDA was submitted under the terms of a license agreement signed
This multi-center, double-blind, randomized and placebo-controlled clinical trial compares the safety and efficacy of prulifloxacin versus placebo in adult travelers suffering acute bacterial gastroenteritis. Clinical trial sites included
This study examines the safety of its lead candidate, new HspE7 (HspE7 + Poly-ICLC, a toll-like receptor-3, or TLR3 agonist), in patients with cervical intraepithelial neoplasia (CIN), a
This trial is being conducted in Europe in healthy volunteers and is designed to help define dosing regimens to assess in patients with inflammatory diseases and cancer. Daryl
According to European Medicines Agency (EMEA), 65 opinions on initial marketing authorizations for medicines for human use were adopted in 2007, 14 more than in 2006. The most-represented
The agreement provides Biological E (BE) with an option for novel production technologies for both heparin- and chondroitin-related carbohydrate compounds. Heparinex and Choncept are funded and managed by
In research relating to atherosclerosis and cellular aging, researchers showed that the introduction of the NamPRT gene into aging human vascular smooth muscle cells delayed their deterioration and
The grant covers four activities, starting with the technical assistance the World Health Organization (WHO) will provide to developing countries that the global fund to fight AIDS, tuberculosis
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.